Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 43Rectal Neoplasms 12Colonic Neoplasms 12Neoplasm Metastasis 6Stomach Neoplasms 5Pancreatic Neoplasms 5Gallbladder Neoplasms 3Colorectal Cancer Metastatic 3Cholangiocarcinoma 3Neutropenia 2Neoplasms 2Bile Duct Neoplasms 2Adenocarcinoma 2mCRC 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumor 1Recurrence 1Pretreated Metastatic Colorectal Cancer 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1Nasopharyngeal Carcinoma 1Microsatellite-stable Colorectal Cancer 1Metastatic Gastric Adenocarcinoma 1High-grade Extra Pulmonary Neuroendocrine Cancer 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Gastric and Gastroesophageal Junction Adenocarcinoma 1Gastric Cancer Adenocarcinoma Metastatic 1Gastric Adenocarcinoma 1

Interventions

Oxaliplatin 3Magnetic Resonance Spectroscopy 3Exercise Test 2Cyclophosphamide 2Capecitabine 2trifluridine tipiracil drug combination 1penpulimab 1pembrolizumab 1lutetium Lu 177 dotatate 1huachansu 1guadecitabine 1copper dotatate CU-64 1XELOX 1Ursodeoxycholic Acid 1Surveys and Questionnaires 1Restraint, Physical 1Physical Examination 1Oviposition 1Observation 1Lutetium-177 1Lutetium 1Irinotecan 1Indocyanine Green 1Hyperthermic Intraperitoneal Chemotherapy 1Health Information Exchange 1Gemcitabine 1Gastroscopy 1Fluorouracil 1Fluorescein 1Endoscopy, Digestive System 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Gastrointestinal Diseases × trifluridine tipiracil drug combination × Clear all
NCT04457297 2026-01-21

ALTAIR

National Cancer Center Hospital East

Phase 3 Completed
243 enrolled 13 charts
Gastrointestinal

Digestive System Diseases, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡